MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027

1.    MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. HISTORY OF IMMUNOHISTOCHEMISTRY

2.2. VALUE CHAIN OUTLOOK

2.3. KEY INSIGHTS

2.4. MARKET ATTRACTIVENESS MATRIX

2.5. MARKET DRIVERS

2.5.1.   IN-VITRO TECHNOLOGICAL ADVANCEMENTS

2.5.2.   INCREASING CANCER OCCURRENCE

2.5.3.   SWELLING HEALTHCARE SPENDING

2.5.4.   RISING GERIATRIC POPULATION

2.5.5.   INCREASING USE OF POC TESTING

2.6. MARKET RESTRAINTS

2.6.1.   RESTRICTIONS OF CLOSED SYSTEMS

2.6.2.   REIMBURSEMENT ISSUES

2.7. MARKET OPPORTUNITIES

2.7.1.   INCREASING USE OF BIOMARKERS FOR DISEASE DIAGNOSIS

2.7.2.   TECHNOLOGICAL ADVANCEMENTS

2.8. MARKET CHALLENGES

2.8.1.   STRINGENT REGULATIONS

2.8.2.   HIGH MAINTENANCE COST INFLUENCING THE MARKET GROWTH

3.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY PRODUCTS

3.1. ANTIBODIES

3.1.1.   PRIMARY ANTIBODIES

3.1.2.   SECONDARY ANTIBODIES

3.2. EQUIPMENT

3.2.1.   SLIDE STAINING SYSTEMS

3.2.2.   TISSUE MICROARRAYS

3.2.3.   TISSUE PROCESSING SYSTEMS

3.2.4.   SLIDE SCANNERS

3.2.5.   OTHER EQUIPMENT

3.3. REAGENTS

3.3.1.   HISTOLOGICAL STAINS

3.3.2.   BLOCKING SERA AND REAGENTS

3.3.3.   CHROMOGENIC SUBSTRATES

3.3.4.   FIXATION REAGENTS

3.3.5.   STABILIZERS

3.3.6.   ORGANIC SOLVENTS

3.3.7.   PROTEOLYTIC ENZYMES

3.3.8.   DILUENTS

3.4. KITS

4.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY APPLICATIONS

4.1. DIAGNOSTICS

4.1.1.   CANCER

4.1.2.   INFECTIOUS DISEASES

4.1.3.   CARDIOVASCULAR DISEASE

4.1.4.   AUTOIMMUNE DISEASES

4.1.5.   DIABETES MELLITUS

4.1.6.   NEPHROLOGICAL DISEASES

4.2. DRUG TESTING

5.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY END-USERS

5.1. HOSPITALS AND DIAGNOSTIC LABORATORIES

5.2. RESEARCH INSTITUTES

5.3. OTHER END-USERS

6.    IMMUNOHISTOCHEMISTRY (IHC) MARKET - MIDDLE EAST AND AFRICA

6.1. COUNTRY ANALYSIS

6.1.1.   SAUDI ARABIA

6.1.2.   THE UNITED ARAB EMIRATES

6.1.3.   TURKEY

6.1.4.   SOUTH AFRICA

6.1.5.   REST OF MIDDLE EAST AND AFRICA

7.    COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ABCAM PLC

7.3. AGILENT TECHNOLOGIES, INC.

7.4. BIOGENEX

7.5. BIO-RAD LABORATORIES, INC.

7.6. BIO SB

7.7. CELL SIGNALING TECHNOLOGY, INC.

7.8. DANAHER CORPORATION

7.9. F. HOFFMANN-LA ROCHE AG

7.10.            HISTOLOGIX

7.11.            MERCK MILLIPORE

7.12.            PERKINELMER, INC.

7.13.            SIEMENS AG HEALTHCARE

7.14.            THERMO FISHER SCIENTIFIC, INC.

8.    METHODOLOGY AND SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

TABLE 1       MIDDLE EAST AND AFRICA MARKET FOR IMMUNOHISTOCHEMISTRY BY REGION 2019-2027 ($ MILLION)

TABLE 2       CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT

TABLE 3        MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 4        MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)

TABLE 5        CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES

TABLE 6        SECONDARY ANTIBODY SELECTIONS

TABLE 7        MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)

TABLE 8        MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)

TABLE 9        HISTOLOGY STAINS AND ITS CATEGORIES

TABLE 10      COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS

TABLE 11      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)

TABLE 12      KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION

TABLE 13      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 14      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)

TABLE 15      SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES

TABLE 16      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY END USERS 2019-2027 ($ MILLION)

TABLE 17     MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURE 1      MIDDLE EAST AND AFRICA MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)

FIGURE 2      HISTORY OF IMMUNOHISTOCHEMISTRY

FIGURE 3      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 4      MIDDLE EAST AND AFRICA ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 5      MIDDLE EAST AND AFRICA ANTIBODIES MARKET IN SECONDARY ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 6      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2019-2027 ($ MILLION)

FIGURE 7      MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2019-2027 ($ MILLION)

FIGURE 8      MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN TISSUE MICROARRAYS 2019-2027 ($ MILLION)

FIGURE 9      MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2019-2027 ($ MILLION)

FIGURE 10  MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN SLIDE SCANNERS 2019-2027 ($ MILLION)

FIGURE 11   MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN OTHER EQUIPMENT 2019-2027 ($ MILLION)

FIGURE 12   MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2019-2027 ($ MILLION)

FIGURE 13   MIDDLE EAST AND AFRICA REAGENTS MARKET IN HISTOLOGICAL STAINS 2019-2027 ($ MILLION)

FIGURE 14   MIDDLE EAST AND AFRICA REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2019-2027 ($ MILLION)

FIGURE 15   MIDDLE EAST AND AFRICA REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2019-2027 ($ MILLION)

FIGURE 16    MIDDLE EAST AND AFRICA REAGENTS MARKET IN FIXATION REAGENTS 2019-2027 ($ MILLION)

FIGURE 17   MIDDLE EAST AND AFRICA REAGENTS MARKET IN STABILIZERS 2019-2027 ($ MILLION)

FIGURE 18  MIDDLE EAST AND AFRICA REAGENTS MARKET IN ORGANIC SOLVENTS 2019-2027 ($ MILLION)

FIGURE 19  MIDDLE EAST AND AFRICA REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2019-2027 ($ MILLION)

FIGURE 20   MIDDLE EAST AND AFRICA REAGENTS MARKET IN DILUENTS 2019-2027 ($ MILLION)

FIGURE 21   PHASES OF HISTOLOGICAL STAINING

FIGURE 22   MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)

FIGURE 23   MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)

FIGURE 24   MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN CANCER 2019-2027 ($ MILLION)

FIGURE 25   MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN INFECTIOUS DISEASES 2019-2027 ($ MILLION)

FIGURE 26   MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)

FIGURE 27   MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)

FIGURE 28   MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN DIABETES MELLITUS 2019-2027 ($ MILLION)

FIGURE 29   MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)

FIGURE 30   MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2019-2027 ($ MILLION)

FIGURE 31   MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 32   MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2019-2027 ($ MILLION)

FIGURE 33   MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END USERS 2019-2027 ($ MILLION)

FIGURE 34   SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 35   TURKEY IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 36   UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 37   SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 38   REST OF MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)